| Authors: |
Wu CY; Department of Pharmacology and Toxicology, University of Toronto, 1 King's College Circle, Toronto, ON, M5S 1A8, Canada.; Dr. Sandra Black Centre for Brain Resilience and Recovery, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, ON, Canada., Alkabbani W; School of Pharmacy, University of Waterloo, Kitchener, ON, Canada., Shah BR; Division of Endocrinology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.; Department of Medicine, University of Toronto, Toronto, ON, Canada.; ICES, Toronto, ON, Canada., Kapral MK; ICES, Toronto, ON, Canada.; Division of General Internal Medicine, Department of Medicine, University of Toronto, Toronto, ON, Canada.; Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada., Edwards JD; School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada.; ICES uOttawa, Ottawa, ON, Canada., Maxwell CJ; School of Pharmacy, University of Waterloo, Kitchener, ON, Canada.; ICES, Toronto, ON, Canada.; School of Public Health Sciences, University of Waterloo, Waterloo, ON, Canada., Swardfager W; Department of Pharmacology and Toxicology, University of Toronto, 1 King's College Circle, Toronto, ON, M5S 1A8, Canada. w.swardfager@utoronto.ca.; Dr. Sandra Black Centre for Brain Resilience and Recovery, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, ON, Canada. w.swardfager@utoronto.ca.; KITE University Health Network Toronto Rehabilitation Institute, Toronto, ON, Canada. w.swardfager@utoronto.ca. |
